Toxoplasma strain nomenclature

Journal of Infectious Diseases

Volumn 200, Issue 6, 2009, Pages 1012-

  Gómez Marín, Jorge Enrique ^a  

^a UNIVERSIDAD DEL QUINDÍO   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

CONGENITAL TOXOPLASMOSIS; GENE LOCUS; GENETIC STRAIN; GENOTYPE; HAPLOTYPE; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; NONHUMAN; PRIORITY JOURNAL; STRAIN IDENTIFICATION; TOXOPLASMA; ANIMAL; CLASSIFICATION; HUMAN; NOMENCLATURE; NOTE; PARASITOLOGY; TOXOPLASMOSIS;

ANIMALS; HUMANS; TERMINOLOGY AS TOPIC; TOXOPLASMA; TOXOPLASMOSIS;

EID: 70349427185     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/605414     Document Type: Letter

References (10)

1. Ajzenberg D, Yera H, Marty P, et al. Genotype of 88 Toxoplasma gondii isolates associated with toxoplasmosis in immunocompromised patients and correlation with clinical findings. J Infect Dis 2009; 199:1155-1167
2. Lehmann T, Marcet PL, Graham DH, Dahl ER, Dubey JP. From the cover: globalization and the population structure of Toxoplasma gondii. Proc Natl Acad Sci U S A 2006; 103: 11423-11428
3. Sibley LD, Ajioka JW Population structure of Toxoplasma gondii clonal expansion driven by infrequent recombination and selective sweeps. Annu Rev Microbiol 2008; 62:329-351
4. Howe DK, Sibley LD. Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease. J Infect Dis 1995; 172:1561-1566
5. 5. Dubey JP, Su Q Cortes JA, et al. Prevalence of Toxoplasma gondii in cats from Colombia, South America and genetic characterization of T gondii isolates. Vet Parasitei 2006; 141:42-47 (Pubitemid 44363137)
6. Morisset S, Peyron F, Lobry J, et al. Serotyping of Toxoplasma gondii striking homogeneous pattern between acute and asymptomatic infections within Europe and South America. Microbes Infect 2008; 10:742-747
7. Peyron F, Lobry JR, Musset K, et al. Serotyping of Toxoplasma gondii in chronically infected pregnant women: predominance of type II in Europe and types I and III in Colombia (South America). Microbes Infect 2006; 8:2333-2340
8. SYROCOT. Effectiveness of prenatal treatment for congenital toxoplasmosis: a metaanalysis of individual patients' data Lancet 2007; 369:115-122
9. Gilbert RE, Freeman K, Lago EG, et al. Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe. The European Multicentre Study on Congenital Toxoplasmosis (EMSCOT). PLoS Negl Trop Dis 2008; 2:e277.
10. 10. Saeij JPJ, Boyle JP, Coller S, Taylor S, Sibley LD. Polymorphic secreted kinases are key virulence factors in toxoplasmosis. Science 2006;314:1780-1783 (Pubitemid 44969090)